Egalet IPO Underwriters Exercise Over-Allotment Option

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WAYNE, Pa., March 10, 2014 (GLOBE NEWSWIRE) -- Egalet Corporation (Nasdaq:EGLT) ("Egalet") today announced that the underwriters of its initial public offering (IPO) have exercised their option to purchase 630,000 shares of common stock at the IPO price of $12.00 per share to cover over-allotments. The sale of these additional shares of common stock closed earlier today. Egalet estimates net proceeds from the offering to be approximately $7.5 million, after deducting underwriting discounts and commissions.

Help employers find you! Check out all the jobs and post your resume.

Back to news